Cabana-Domínguez, Judit http://orcid.org/0000-0002-4732-7284
Soler Artigas, María http://orcid.org/0000-0002-3213-1107
Arribas, Lorena
Alemany, Silvia
Vilar-Ribó, Laura http://orcid.org/0000-0001-8758-523X
Llonga, Natalia
Fadeuilhe, Christian
Corrales, Montse
Richarte, Vanesa
Ramos-Quiroga, Josep Antoni http://orcid.org/0000-0003-1622-0350
Ribasés, Marta http://orcid.org/0000-0003-1039-1116
Article History
Received: 5 May 2022
Revised: 8 September 2022
Accepted: 13 September 2022
First Online: 24 September 2022
Conflict of interest
: J.A.R.Q. was on the speakers bureau and/or acted as consultant for Janssen-Cilag, Novartis, Shire, Takeda, Bial, Shionogi, Sincrolab, Novartis, BMS, Medice, Technofarma, Rubió and Raffo in the last 3 years. He also received travel awards (air tickets + hotel) for taking part in psychiatric meetings from Janssen-Cilag, Rubió, Shire, Takeda, Shionogi, Bial, and Medice. The Department of Mental Health chaired by him received unrestricted educational and research support from the following companies in the last 3 years: Janssen-Cilag, Shire, Oryzon, Roche, Psious, and Rubió. C.F. and V.R. have received fees to give talks for Shire/Takeda and Rubió. All other authors declare no biomedical financial interests or conflicts of interest.